<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Koronavirus ilmiy tadqiqotlari o'zbek tilida]]></title><description><![CDATA[A starter blog demonstrating what Gatsby can do.]]></description><link>https://gatsby-starter-blog-demo.netlify.app</link><generator>GatsbyJS</generator><lastBuildDate>Sun, 19 Jul 2020 19:33:23 GMT</lastBuildDate><item><title><![CDATA[Yaponiyaning 'Avigan' deb nomlanuvchi antibiotiki qanchalik foydali?]]></title><description><![CDATA[Business Today saytida aytilishicha ushbu dori vositasi kutilgan natijani bermagan. Fujifilm Holdings Corp kompaniyasi tomonidan ishlangan…]]></description><link>https://gatsby-starter-blog-demo.netlify.app/avigan/</link><guid isPermaLink="false">https://gatsby-starter-blog-demo.netlify.app/avigan/</guid><pubDate>Mon, 20 Jul 2020 22:45:32 GMT</pubDate><content:encoded>&lt;p&gt;&lt;span
      class=&quot;gatsby-resp-image-wrapper&quot;
      style=&quot;position: relative; display: block; margin-left: auto; margin-right: auto; max-width: 590px; &quot;
    &gt;
      &lt;a
    class=&quot;gatsby-resp-image-link&quot;
    href=&quot;/bloglar/static/d6021b90056b778df6acaaa856f922b8/ee745/avigan.jpg&quot;
    style=&quot;display: block&quot;
    target=&quot;_blank&quot;
    rel=&quot;noopener&quot;
  &gt;
    &lt;span
    class=&quot;gatsby-resp-image-background-image&quot;
    style=&quot;padding-bottom: 68.24324324324324%; position: relative; bottom: 0; left: 0; background-image: url(&apos;data:image/jpeg;base64,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&apos;); background-size: cover; display: block;&quot;
  &gt;&lt;/span&gt;
  &lt;img
        class=&quot;gatsby-resp-image-image&quot;
        alt=&quot;Chinese Salty Egg&quot;
        title=&quot;Chinese Salty Egg&quot;
        src=&quot;/bloglar/static/d6021b90056b778df6acaaa856f922b8/1c72d/avigan.jpg&quot;
        srcset=&quot;/bloglar/static/d6021b90056b778df6acaaa856f922b8/a80bd/avigan.jpg 148w,
/bloglar/static/d6021b90056b778df6acaaa856f922b8/1c91a/avigan.jpg 295w,
/bloglar/static/d6021b90056b778df6acaaa856f922b8/1c72d/avigan.jpg 590w,
/bloglar/static/d6021b90056b778df6acaaa856f922b8/ee745/avigan.jpg 660w&quot;
        sizes=&quot;(max-width: 590px) 100vw, 590px&quot;
        style=&quot;width:100%;height:100%;margin:0;vertical-align:middle;position:absolute;top:0;left:0;&quot;
        loading=&quot;lazy&quot;
      /&gt;
  &lt;/a&gt;
    &lt;/span&gt;&lt;/p&gt;
&lt;h2&gt;&lt;a href=&quot;https://www.businesstoday.in/sectors/pharma/coronavirus-drug-clinical-trial-of-fujifilm-avigan-drug-yields-inconclusive-results/story/409474.html&quot;&gt;Business Today&lt;/a&gt; saytida aytilishicha ushbu dori vositasi kutilgan natijani bermagan.&lt;/h2&gt;
&lt;p&gt;Fujifilm Holdings Corp kompaniyasi tomonidan ishlangan ‘Avigan’ dori vositasining (tarkibida Favipiravir bor) klinik sinovi COVID-19 davolashda kutilgan natijalarni bermadi, deb yapon tadqiqotchilari 10-iyul 2020 yil xabar berdi . Fujita sog’liqni saqlash universiteti tadqiqotchisi Yoxey Doining so’zlariga ko’ra, sinovning boshida preparatni qabul qilgan bemorlar kechiktirilgan dozalarga qaraganda ko’proq ijobiy ta’sirlarni sezishgan, ammo natijalar statistik ahamiyatga ega bo’lmagan.&lt;/p&gt;
&lt;p&gt;10-iyul 2020 yil kuni bo’lib o’tgan matbuot anjumanida e’lon qilingan natijalar mart va may oylari orasida Yaponiya bo’ylab 89 bemorda o’tkazilgan klinik sinovlar yakunlandi. Yaponiya Bosh vaziri Shinzo Abe, ushbu dori may oyida COVID-19 davosi sifatida tasdiqlanadi deb umid qilgan edi, ammo Yaponiyada bemorlarning yetishmasligi klinik sinovlar jarayonini kechiktirdi. Ushbu vosita xozirda Rossiya va Hindistonda COVID-19 davolash usuli sifatida tasdiqlangan.&lt;/p&gt;
&lt;h2&gt;Lekin yana bir &lt;a href=&quot;https://www.japantimes.co.jp/news/2020/07/18/national/science-health/fujifilm-start-another-avigan-study-kuwait-following-setback-japan/#.XxQWdHUzZhE&quot;&gt;Yapon axborot agentligida&lt;/a&gt; sinovlar qaytadan Quvayt davlatida boshlanishini e’lon qilingan&lt;/h2&gt;
&lt;p&gt;Fujifilm Holdings Corp. Quvaytda Hindistonlik hamkorlari bilan ‘Avigan’ virusiga qarshi dori vositasi ustida klinik o’rganishni qayta boshlaydi, deya xabar 18-iyul 2020 yil kuni berdi.&lt;/p&gt;
&lt;p&gt;Sinov jarayoni asosan Hindistonning doktor Reddy’s Laboratories Ltd kompaniyasi tomonidan o’tkazilishi kutilmoqda va unda grippga qarshi dori samaradorligini baholash uchun 1000 nafargacha odam qatnashadi, deya xabar beradi.&lt;/p&gt;
&lt;p&gt;Jons Xopkins universiteti ma’lumotlariga ko’ra Quvaytda 18-iyul kuniga ko’ra 58,200 dan ortiq COVID-19 holatlarini qayd etgan. Agar Kuvayt tadqiqotidan samarali natijalar olinsa, undan Yaponiyada ham foydalanish kutilmoqda.&lt;/p&gt;
&lt;p&gt;Bosh vazir Sindzo Abe, may oyining oxirida koronavirusga qarshi kurashishda ushbu doridan foydalanish rasman tasdiqlanishiga umid qilgan edi, ammo o’sha oy Fujita sog’liqni saqlash universitetining Aviganning COVID-19 ga qarshi samarali emasligi haqidagi hisobotidan keyin u bundan voz kechdi.&lt;/p&gt;
&lt;h6&gt;Muallifdan:&lt;/h6&gt;
&lt;p&gt;Ushbu maqola &lt;strong&gt;internet manbalarining tarjimasi bo’lib&lt;/strong&gt;, davolanishdan avval albatta shifokor bilan maslaxatlashishingizni so’raymiz. Xatolar va kamchiliklarini ushbu pochtaga yuborishingiz mumkin &lt;strong&gt;muslimchik.inha@gmail.com&lt;/strong&gt;&lt;/p&gt;</content:encoded></item><item><title><![CDATA[Antibiotiklar foydalimi?]]></title><description><![CDATA[Yo’q. Antibiotiklar viruslarga qarshi foyda bermaydi. Ular faqatgina bakterial infektsiyalar uchun ishlatiladi. COVID-19 virusdan kelib…]]></description><link>https://gatsby-starter-blog-demo.netlify.app/antibiotiklar/</link><guid isPermaLink="false">https://gatsby-starter-blog-demo.netlify.app/antibiotiklar/</guid><pubDate>Mon, 20 Jul 2020 22:40:32 GMT</pubDate><content:encoded>&lt;p&gt;&lt;span
      class=&quot;gatsby-resp-image-wrapper&quot;
      style=&quot;position: relative; display: block; margin-left: auto; margin-right: auto; max-width: 590px; &quot;
    &gt;
      &lt;a
    class=&quot;gatsby-resp-image-link&quot;
    href=&quot;/bloglar/static/27e20e06cded4baf733b4e22590ca9c5/f058b/antibiotic.png&quot;
    style=&quot;display: block&quot;
    target=&quot;_blank&quot;
    rel=&quot;noopener&quot;
  &gt;
    &lt;span
    class=&quot;gatsby-resp-image-background-image&quot;
    style=&quot;padding-bottom: 60.13513513513513%; position: relative; bottom: 0; left: 0; background-image: url(&apos;data:image/png;base64,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&apos;); background-size: cover; display: block;&quot;
  &gt;&lt;/span&gt;
  &lt;img
        class=&quot;gatsby-resp-image-image&quot;
        alt=&quot;Chinese Salty Egg&quot;
        title=&quot;Chinese Salty Egg&quot;
        src=&quot;/bloglar/static/27e20e06cded4baf733b4e22590ca9c5/fcda8/antibiotic.png&quot;
        srcset=&quot;/bloglar/static/27e20e06cded4baf733b4e22590ca9c5/12f09/antibiotic.png 148w,
/bloglar/static/27e20e06cded4baf733b4e22590ca9c5/e4a3f/antibiotic.png 295w,
/bloglar/static/27e20e06cded4baf733b4e22590ca9c5/fcda8/antibiotic.png 590w,
/bloglar/static/27e20e06cded4baf733b4e22590ca9c5/f058b/antibiotic.png 630w&quot;
        sizes=&quot;(max-width: 590px) 100vw, 590px&quot;
        style=&quot;width:100%;height:100%;margin:0;vertical-align:middle;position:absolute;top:0;left:0;&quot;
        loading=&quot;lazy&quot;
      /&gt;
  &lt;/a&gt;
    &lt;/span&gt;&lt;/p&gt;
&lt;p&gt;Yo’q. Antibiotiklar viruslarga qarshi foyda bermaydi. Ular faqatgina bakterial infektsiyalar uchun ishlatiladi. COVID-19 virusdan kelib chiqadi, shuning uchun antibiotiklar xech qanday davoga ega emas. Antibiotiklar COVID-19 ning oldini olish yoki davolash vositasi sifatida ishlatilmasligi kerak. Kasalxonalarda shifokorlar ba’zida og’ir kasal bemorlarga COVID-19 asoratlariga olib keladigan ikkilamchi bakterial infektsiyalarni oldini olish yoki davolash uchun antibiotiklardan foydalanishadi. Ular &lt;strong&gt;faqat bakterial infektsiyani&lt;/strong&gt; davolash uchun &lt;strong&gt;shifokor ko’rsatmasi&lt;/strong&gt; bo’yicha &lt;strong&gt;qo’llanilishi kerak&lt;/strong&gt;.&lt;/p&gt;
&lt;h6&gt;Muallifdan:&lt;/h6&gt;
&lt;p&gt;Ushbu maqola JSST tashkilotining &lt;a href=&quot;https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/q-a-coronaviruses&quot;&gt;ushbu saxifasi&lt;/a&gt; tarjimasi bo’lib, davolanishdan avval albatta shifokor bilan maslaxatlashishingizni so’raymiz. Xatolar va kamchiliklarini ushbu pochtaga yuborishingiz mumkin &lt;strong&gt;muslimchik.inha@gmail.com&lt;/strong&gt;&lt;/p&gt;</content:encoded></item><item><title><![CDATA[Buyuk Britaniya olimlarining deksametazon ustida olib borgan ilmiy ishlari natijalari]]></title><description><![CDATA[Jahon Sog’liqni Saqlash Tashkiloti, Buyuk Britaniyada olib borilgan korksikosteroid (corticosteroid) deksametazonni, COVID-19 ning og’ir ko…]]></description><link>https://gatsby-starter-blog-demo.netlify.app/deksametazon/</link><guid isPermaLink="false">https://gatsby-starter-blog-demo.netlify.app/deksametazon/</guid><pubDate>Sun, 19 Jul 2020 22:40:32 GMT</pubDate><content:encoded>&lt;p&gt;Jahon Sog’liqni Saqlash Tashkiloti, Buyuk Britaniyada olib borilgan korksikosteroid (corticosteroid) deksametazonni, COVID-19 ning og’ir ko’rinishidagi turi bilan kasallangan bemorlarining hayotini saqlab qolishi mumlkin ekanligini ko’rsatadigan dastlabki klinik sinovlarini yuqori baxolashdi. Sun’iy nafas olishda bo’lgan og’ir axvoldagi bemorlarda ushbu usulda davolash, o’limni uchdan bir qismga qisqartirishi va faqat kislorodga ehtiyoj sezadigan bemorlarda esa o’limni taxminan beshdan biriga kamaytirishi isbotlandi.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Eslatma&lt;/strong&gt;: Deksametazonning &lt;strong&gt;foydasi&lt;/strong&gt; faqatgina &lt;strong&gt;og’ir axvoldagi&lt;/strong&gt; COVID-19 bilan og’rigan bemorlarda kuzatilgan va yengil axvoldagi bemorlarda undan foydalanish sog’likka xavli bo’lishi mumkin. &lt;a href=&quot;https://www.who.int/news-room/q-a-detail/q-a-dexamethasone-and-covid-19&quot;&gt;JSST rasmiy saytidan olindi&lt;/a&gt;.&lt;/p&gt;
&lt;h2&gt;Deksametazon nima va u COVID-19 ga qarshi foydalimi?&lt;/h2&gt;
&lt;p&gt;Deksametazon bu yallig’lanishga qarshi va immunosupressant ta’sirga ega bo’lish uchun keng miqiysada ishlatiladigan kortikosteroiddir(corticosteroid). U Buyuk Britaniyaning &lt;em&gt;RECOVERY&lt;/em&gt; milliy klinik sinovida COVID-19 bilan kasalxonaga yotqizilgan bemorlarda sinovdan o’tkazilib, og’ir kasaaxvoldagi bemorlarga foydali ekanligi aniqlandi. JSST bilan taqqoslangan dastlabki ma’lumotlarga ko’ra, sun’iy nafas olishdagi bemorlarda davolash o’limni uchdan bir qismga, va faqat kislorod talab qiladigan bemorlarning o’limini taxminan beshdan biriga kamaytirdi.&lt;/p&gt;
&lt;h2&gt;Stereoidlar (Deksametazon ham stereoid) yoshi kattalarda, bolalarda, homiladorlarda qo’llansa bo’ladimi ?&lt;/h2&gt;
&lt;p&gt;Steroidlardan bolalar va qariyalar uchun foydalanish mumkin. Homiladorlar uchun esa &lt;em&gt;RECOVERY&lt;/em&gt; sinovida prednizolonning og’iz orqali yoki gidrokortizon deksametazonning o’rniga vena ichiga infuziya yordamida yuborilgan. &lt;strong&gt;Steroidlar foydalanish nuqtai nazaridan har xil&lt;/strong&gt;.&lt;/p&gt;
&lt;h2&gt;Klinik sinovlarda qanday dozalardan foydalanilgan?&lt;/h2&gt;
&lt;p&gt;Deksametazon &lt;em&gt;RECOVERY&lt;/em&gt;  tomonidan o’tkazilgan sinovida o’n kun davomida kuniga bir marta 6 mg dan og’iz orqali (suyuqlik yoki tabletka ko’rinishida) yoki tomir ichiga yuborilgan. Homilador yoki emizikli ayollarda esa deksametazon o’rniga, &lt;em&gt;40 mg&lt;/em&gt; lik prednizolon og’iz orqali yuborildi (yoki kuniga ikki marta 80 mg gidrokortizon).&lt;/p&gt;
&lt;h2&gt;Deksametazonning aks ta’sirlari nimalar?&lt;/h2&gt;
&lt;p&gt;Deksametazon umumiy olganda xavfsiz. Bu, ayniqsa, pnevmoniyaning og’ir shakllari bo’lgan bemorlarda foydaliligi ortgan xolda, og’ir bo’lmagan pnevmoniya bilan kasallangan bemorlarda foyda unchalik katta emas. Davolanish qisqa bo’lgandagina, kortikosteroidlar yuqori dozalarda yuborilsa ham jiddiy aks ta’sirlarga ega bo’lmaydi. Lekin, vaqtinchalik &lt;strong&gt;qonda glyukoza&lt;/strong&gt; miqdorining &lt;strong&gt;oshishiga&lt;/strong&gt; olib kelishi mumkin (giperglikemiya).&lt;/p&gt;
&lt;p&gt;Uzoq muddatli davolashda (ya’ni, ikki haftadan ko’proq vaqt davomida davolashda) glaukoma (glaucoma), katarakta (cataract), suyuqlikni me’yorida saqlab tura olmaslik (fluid retention), gipertenziya (hypertension), psixologik ta’sirlar (masalan, kayfiyat o’zgarishi, xotira muammolari, tartibsizlik yoki qichitish xususiyati), vazn ortishi yoki infektsiyalar va osteoporoz xavfi ortishi kabi noxush hodisalarga sabab bo’lishi mumkin. &lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Eslatma:&lt;/strong&gt; Ushbu barcha salbiy holatlar qisqa muddatli davolanish bilan bog’liq emas (diabetni kuchaytiradigan giperglikemiya (hyperglycaemia) bundan mustasno).&lt;/p&gt;
&lt;h3&gt;Klinik sinovdagi barcha ko’ngillilarga deksametazon yuborilganmidi?&lt;/h3&gt;
&lt;p&gt;Sinovlardagi bemorlar tasodifiy ravishda bir nechta davolash guruxlariga taqsimlangan. Deksametazon og’iz orqali (suyuqlik yoki tabletka ko’rinishida) yoki kuniga bir marta 6 mg dozada o’n kun davomida qo’llarning biridagi tomirlariga yuborilgan.&lt;/p&gt;
&lt;p&gt;Homilador va emizikli ayollar guruxlarga bo’lingan xolda bemorlarning og’iz yo’li orqali prednizolon (kuchsiz kortikosteroid) yuboriladigan.&lt;/p&gt;
&lt;h6&gt;Muallifdan:&lt;/h6&gt;
&lt;p&gt;Ushbu maqola JSST tashkilotining &lt;a href=&quot;https://www.who.int/news-room/q-a-detail/q-a-dexamethasone-and-covid-19&quot;&gt;ushbu saxifasi&lt;/a&gt; tarjimasi bo’lib, davolanishdan avval albatta shifokor bilan maslaxatlashishingizni so’raymiz. Xatolar va kamchiliklarini ushbu pochtaga yuborishingiz mumkin &lt;strong&gt;muslimchik.inha@gmail.com&lt;/strong&gt;&lt;/p&gt;</content:encoded></item><item><title><![CDATA[Chaqaloqlarni emizish va COVID-19]]></title><description><![CDATA[Ko’krak suti va emizish orqali faol COVID-19 (infektsiyani keltirib chiqarishi mumkin bo’lgan virus) yuqishi bugungi kungacha aniqlanmagan…]]></description><link>https://gatsby-starter-blog-demo.netlify.app/emiziklilik/</link><guid isPermaLink="false">https://gatsby-starter-blog-demo.netlify.app/emiziklilik/</guid><pubDate>Wed, 20 May 2015 20:12:03 GMT</pubDate><content:encoded>&lt;p&gt;Ko’krak suti va emizish orqali faol COVID-19 (infektsiyani keltirib chiqarishi mumkin bo’lgan virus) yuqishi bugungi kungacha aniqlanmagan. Emizishni to’xtatish uchun hech qanday sabab yo’q&lt;/p&gt;
&lt;h2&gt;COVID-19 tasdiqlangan bemor ayollar chaqaloqlarini emizishda davom etishi xavfsizmi?&lt;/h2&gt;
&lt;p&gt;Ha. COVID-19 tasdiqlangan yoki shubha ostida bo’lgan ayollar, agar xohlasalar, emizishlari mumkin.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Ular ushbu qoidarga amal qilishlari zarur&lt;/strong&gt;:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Qo’llarni tez-tez sovun va suv bilan yoki tarkibida spirt bo’lgan antiseptik vositalarni qo’llang, ayniqsa bolaga tegmasdan oldin;&lt;/li&gt;
&lt;li&gt;Kichkintoy bilan har qanday aloqa paytida, shu jumladan ovqatlantirish paytida tibbiy niqob taqing;&lt;/li&gt;
&lt;li&gt;Aksirish yoki yo’talishda bir martalik salfetkalardan foydalaning. Keyin uni darhol yo’q qiling va qo’lingizni yana yuving;&lt;/li&gt;
&lt;li&gt;Onalar tegizgan yuzalarni muntazam ravishda tozalang va dezinfektsiya qiling.&lt;/li&gt;
&lt;li&gt;Tibbiy niqoblarni nam bo’lgandan keyin almashtirish va ularni darhol yo’q qilish juda muhimdir. Maskalarni qayta ishlatmaslik yoki old tomondan tegmaslik kerak.&lt;/li&gt;
&lt;/ul&gt;
&lt;h2&gt;COVID-19 tasdiqlanganman lekin emizishga juda xam xolsizman&lt;/h2&gt;
&lt;p&gt;Agar siz COVID-19 yoki boshqa asoratlar tufayli bolangizni ko’krak suti bilan boqa olmasangiz, sizga imkon qadar, mavjud va ma’qul tarzda, bolangizni ona sutining o’rinini bosuvchilar bilan ta’milashingiz kerak.
&lt;strong&gt;Bunga quyidagilar kiradi:&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Sut maxsulotlari;&lt;/li&gt;
&lt;li&gt;Donor emizuvchi suti (o’zga ayollardan o’rnigizga emizishni so’rang).&lt;/li&gt;
&lt;/ul&gt;
&lt;h6&gt;Muallifdan:&lt;/h6&gt;
&lt;p&gt;Ushbu maqola JSST tashkilotining &lt;a href=&quot;https://www.who.int/news-room/q-a-detail/q-a-dexamethasone-and-covid-19&quot;&gt;ushbu saxifasi&lt;/a&gt; tarjimasi bo’lib, davolanishdan avval albatta shifokor bilan maslaxatlashishingizni so’raymiz. Xatolar va kamchiliklarini ushbu pochtaga yuborishingiz mumkin &lt;strong&gt;muslimchik.inha@gmail.com&lt;/strong&gt;&lt;/p&gt;</content:encoded></item><item><title><![CDATA[Remdesivir for the Treatment of Covid-19!]]></title><description><![CDATA[Qanday o’tkazildi? Sinovda preparatning besh kunlik va o’n kunlik davolash standardlari asosida va shuning bilan bir paytda boshqa bir guru…]]></description><link>https://gatsby-starter-blog-demo.netlify.app/remedisivir/</link><guid isPermaLink="false">https://gatsby-starter-blog-demo.netlify.app/remedisivir/</guid><pubDate>Wed, 06 May 2015 23:46:37 GMT</pubDate><content:encoded>&lt;p&gt;&lt;span
      class=&quot;gatsby-resp-image-wrapper&quot;
      style=&quot;position: relative; display: block; margin-left: auto; margin-right: auto; max-width: 590px; &quot;
    &gt;
      &lt;a
    class=&quot;gatsby-resp-image-link&quot;
    href=&quot;/bloglar/static/1851c3e3b651e44158bba61da46de0af/4b190/remesidivir.jpg&quot;
    style=&quot;display: block&quot;
    target=&quot;_blank&quot;
    rel=&quot;noopener&quot;
  &gt;
    &lt;span
    class=&quot;gatsby-resp-image-background-image&quot;
    style=&quot;padding-bottom: 56.08108108108109%; position: relative; bottom: 0; left: 0; background-image: url(&apos;data:image/jpeg;base64,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&apos;); background-size: cover; display: block;&quot;
  &gt;&lt;/span&gt;
  &lt;img
        class=&quot;gatsby-resp-image-image&quot;
        alt=&quot;Remesidivir&quot;
        title=&quot;Remesidivir&quot;
        src=&quot;/bloglar/static/1851c3e3b651e44158bba61da46de0af/1c72d/remesidivir.jpg&quot;
        srcset=&quot;/bloglar/static/1851c3e3b651e44158bba61da46de0af/a80bd/remesidivir.jpg 148w,
/bloglar/static/1851c3e3b651e44158bba61da46de0af/1c91a/remesidivir.jpg 295w,
/bloglar/static/1851c3e3b651e44158bba61da46de0af/1c72d/remesidivir.jpg 590w,
/bloglar/static/1851c3e3b651e44158bba61da46de0af/4b190/remesidivir.jpg 800w&quot;
        sizes=&quot;(max-width: 590px) 100vw, 590px&quot;
        style=&quot;width:100%;height:100%;margin:0;vertical-align:middle;position:absolute;top:0;left:0;&quot;
        loading=&quot;lazy&quot;
      /&gt;
  &lt;/a&gt;
    &lt;/span&gt;&lt;/p&gt;
&lt;h2&gt;Qanday o’tkazildi?&lt;/h2&gt;
&lt;p&gt;Sinovda preparatning besh kunlik va o’n kunlik davolash standardlari asosida va shuning bilan bir paytda boshqa bir guru bemorlar platsebo dori vositalari bilan davolash kurslar olib borildi. Ma’lumotlarga ko’ra, besh kunlik remdesivir bilan davolash kursidagi bemorlar 11-kunida tibbiy yordam standartlariga qaraganda 65% ko’proq klinik yaxshilanishlarga ega bo’lishgan. &lt;/p&gt;
&lt;p&gt;Kompaniya ta’kidlashicha, remdesivirni davolashning o’n kunlik davolash kursi kutilgan natija bermagan, ammo tibbiy yordam standartiga nisbatan klinik holatni yaxshilagan. Olimlar har ikkala davolash guruhida remdesivir bilan bog’liq yangi xavflarga duch kelishmadi. Preparat umuman olganda bemorlar tomonidan yaxshi qabul qilingan.&lt;/p&gt;
&lt;p&gt;Olimlardan biri &lt;em&gt;Merdad Parsi&lt;/em&gt; shunday dedi: &lt;/p&gt;
&lt;blockquote&gt;
&lt;p&gt;“Bugungi natijalar shuni ko’rsatdiki, o’rtacha ahvoldagi kasallikni davolashda, besh kunlik remdesivir davolash kursi ushbu dorisiz davolashga qaraganda klinik jihatdan
ko’proq yaxshi natijalarga olib keldi va remedesivirning ijobiy natijalari xaqida dalillariga yana bir dalil bo’lib ushbu tadqiqot o’z natijasini qo’shadi.&lt;/p&gt;
&lt;/blockquote&gt;
&lt;p&gt;‘The National Institute of Allergy and Infectious Diseases’ tomonidan olib borilgan tadqiqotlar remdesivirning davolanish muddatini qisqartirishi va avvalgi davolash usullaridan ko’ra ko’proq ijobiy natijalarni ko’rsatdi.&lt;/p&gt;
&lt;p&gt;“Bizning sodda-jiddiy (SIMPLE-Severe) nomli tadqiqotlarimiz shuni ko’rsatdiki, og’ir kasallikka chalingan bemorlarni davolashda, besh kunlik remdesivir, o’n kunlik kursga o’xshash natijalarni ko’rsatdi.”&lt;/p&gt;
&lt;p&gt;‘SIMPLE’ sinovida kasalxonaga yotqizilgan Covid-19 bemorlarida pnevmoniya borligi tasdiqlangan, lekin kislorod miqdori kamaymaganlar tanlab olingan.&lt;/p&gt;
&lt;p&gt;Sinovning birlamchi yakuniy bosichi 11-kundagi klinik holat deb belgilab olingan, bunda kasalxonadan javob berish, yuborilayotgan kislorod miqdorini oshirish, sun’iy nafas berish qurilmasiga ulash va o’lim bilan yakunlangan. Ikkilamchi maqsad esa sinovlar yakunida, har bir remdesivir qabul qilgan bemorlar guruhidagi salbiy natijalarning remesidivirsiz davolash kurslariga nisbatan xajmini o’lchash va ijobiy holatlarni o’rganish qilib belgilangan.&lt;/p&gt;
&lt;p&gt;Ushbu preparat Yaponiyada Covid-19 kasalligini davolash uchun tasdiqlangan va AQSh oziq-ovqat va dorilar boshqarmasi (FDA) og’ir xoldagi Covid-19 bemorlarni davolash uchun favqulodda foydalanish uchun ruxsatnoma oldi. &lt;/p&gt;</content:encoded></item></channel></rss>